Drug profile

The FDA adverse-event record for B.Burgdoriferi, I. Canicola, I. Grippotyphosa, I.Ictero, I. Pomona

Name: B.Burgdoriferi, I. Canicola, I. Grippotyphosa, I.Ictero, I. Pomona - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

18 FDA reports name B.Burgdoriferi, I. Canicola, I. Grippotyphosa, I.Ictero, I. Pomona, a lower-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#1886 of 2,679
by report volume (all drugs): 18
adverse-event reports: 0.0%
death-coded share: Dog
most-reported species

Compiled by PlainBreed

Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, B.Burgdoriferi, I. Canicola, I. Grippotyphosa, I.Ictero, I. Pomona ranks #1884 of 2679 by total reports (18). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1): 97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1): #1884
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. B.Burgdoriferi, I. Canicola, I. Grippotyphosa, I.Ictero, I. Pomona has 18 reports now versus 18 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: +0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to B.Burgdoriferi, I. Canicola, I. Grippotyphosa, I.Ictero, I. Pomona changes

Signature read: B.Burgdoriferi, I. Canicola, I. Grippotyphosa, I.Ictero, I. Pomona's 0.0% death-coded share is among the lowest in the openFDA drug corpus.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death-coded share of reports

Active Ingredients

B.Burgdoriferi, I. Canicola, I. Grippotyphosa, I.Ictero, I. Pomona

Administration Routes

UnknownSubcutaneous

Species Affected

Dog 18

Most Affected Breeds

Retriever - Labrador 3

Dachshund (unspecified) 2

Terrier - Bull - American Pit 2

Schnauzer - Miniature 1

Spitz - German Pomeranian 1

Retriever - Golden 1

Siberian Husky 1

Retriever (unspecified) 1

Great Pyrenees 1

Hound (unspecified) 1

Most Reported Reactions

Facial swelling (see also 'Skin') 4

Lethargy (see also Central nervous system depression in 'Neurological') 4

Vomiting 4

Seizure NOS 4

Hives (see also 'Skin') 2

Anaphylaxis 2

Anorexia 2

Pruritus 2

Diarrhoea 2

Collapse NOS (see also 'Cardio-vascular' and 'Neurological disorders') 2

Rubbing 1

Itching 1

Outcome Breakdown

Ongoing

11 (61.1%)

Recovered/Normal

7 (38.9%)

B.Burgdoriferi, I. Canicola, I. Grippotyphosa, I.Ictero, I. Pomona: low death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full drug directory to compare report counts across products. All drugs

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for B.Burgdoriferi, I. Canicola, I. Grippotyphosa, I.Ictero, I. Pomona (#1886 of 2,679 by report volume); death-coded 0.0%. PlainBreed drug row · death-coded share stamp 0.0% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →